Randomised, double-blind study of estramustine phosphate and leuprolide acetate.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D004961:Estramustine / Q000627:therapeutic use*; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D016729:Leuprolide; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy*; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D011897:Random Allocation
D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D007987:Gonadotropin-Releasing Hormone; D004961:Estramustine; D016729:Leuprolide